AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32767506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + cellulase (10,000 unit/kg FM)
Number of subjects: 0
Study 32767506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0
Study 32767506 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated rice straw)
Number of subjects: 0
Study 33221363 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited transport to a hospital for potential ECPR
Number of subjects: 400
Study 33221363 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 400
Study 36036095 — intervention group
Group type: EXPERIMENTAL
Intervention: Clustered missed doses
Number of subjects: 3724
Study 36036095 — intervention group
Group type: COMPARATOR
Intervention: No treatment days missed
Number of subjects: 3724
Study 34137446 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant patch
Number of subjects: 247
Study 34137446 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 247
Study 34137446 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of fibrin patch
Number of subjects: 247
Study 34137446 — intervention group
Group type: COMPARATOR
Intervention: Meta-analysis of control
Number of subjects: 247
Study 32438267 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week, home-based, physiotherapist-guided exercise program
Number of subjects: 41
Study 32438267 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 41
Study 36849935 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal thermoplastic orthosis in a neutral position
Number of subjects: 32
Study 36849935 — intervention group
Group type: COMPARATOR
Intervention: Buddy loops
Number of subjects: 32
Study 33355909 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel
Number of subjects: 140
Study 33355909 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 140
Study 32456979 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 20
Study 32456979 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 20
Study 35799553 — intervention group
Group type: EXPERIMENTAL
Intervention: Triidothyronine 1 mic/kg 10 doses 8th hourly given orally postoperatively
Number of subjects: 88
Study 35799553 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sugar sachets)
Number of subjects: 88
Study 33635908 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) approach using a genetic risk score (GRS) based on 14 AAM-associated single nucleotide polymorphisms (SNPs)
Number of subjects: 4093
Study 33635908 — intervention group
Group type: EXPERIMENTAL
Intervention: Generation-standardized AAM (gsAAM)
Number of subjects: 4093
Study 33635908 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage least squares (2SLS) approach employing a univariate GRS
Number of subjects: 4093
Study 33635908 — intervention group
Group type: EXPERIMENTAL
Intervention: MR diagnostics
Number of subjects: 4093
Study 32321387 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and educational group intervention
Number of subjects: 35
Study 35946332 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release morphine and subcutaneous morphine (rapid titration)
Number of subjects: 108
Study 35946332 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous morphine (control)
Number of subjects: 108
Study 34620117 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronome-based technique
Number of subjects: 42
Study 34620117 — intervention group
Group type: COMPARATOR
Intervention: Standard stopwatch-based technique
Number of subjects: 42
Study 32388868 — intervention group
Group type: EXPERIMENTAL
Intervention: VER group (vitamin E-enriched transgenic maize)
Number of subjects: 360
Study 32388868 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive control group (non-GM maize plus exogenous vitamin E)
Number of subjects: 360
Study 32388868 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (non-GM maize)
Number of subjects: 360
Study 34908019 — intervention group
Group type: EXPERIMENTAL
Intervention: Regadenoson
Number of subjects: 200
Study 34908019 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole
Number of subjects: 200
Study 34515194 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 277
Study 35179323 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide (600 mg twice daily)
Number of subjects: 1306
Study 35179323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study 35179323 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 1306
Study 35179323 — intervention group
Group type: COMPARATOR
Intervention: Darolutamide and Placebo
Number of subjects: 1306
Study 34692441 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily for 10 days
Number of subjects: 60
Study 34692441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35569564 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation (NT‐proBNP, troponin T, cystatin C, GDF‐15, IL‐6, CRP)
Number of subjects: 11818
Study 35569564 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation
Number of subjects: 11818
Study 36050387 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pay-off, geographically targeted lotteries in treated zip codes
Number of subjects: 0
Study 36050387 — intervention group
Group type: COMPARATOR
Intervention: Control zip codes
Number of subjects: 0
Study 32124049 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop ileostomy closure
Number of subjects: 216
Study 32124049 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 216
Study 32124049 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 216
Study 32124049 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical and radiological diagnosis
Number of subjects: 216
Study 32124049 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors
Number of subjects: 216
Study 34856838 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile kinesio taping
Number of subjects: 56
Study 34856838 — intervention group
Group type: COMPARATOR
Intervention: Standardized postoperative physiotherapy
Number of subjects: 56
Study 34060988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuyuxunxi (CYXX) prescription
Number of subjects: 10
Study 34060988 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 10
Study 32188697 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium dialysate (135 mM)
Number of subjects: 99
Study 32188697 — intervention group
Group type: COMPARATOR
Intervention: Conventional dialysate (140 mM)
Number of subjects: 99
Study 35339954 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized and progressive multicomponent exercise program (6 months)
Number of subjects: 112
Study 35339954 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (Control)
Number of subjects: 112
Study 34961531 — intervention group
Group type: EXPERIMENTAL
Intervention: i-ACT training (3×45 min/week for 6 weeks)
Number of subjects: 47
Study 34961531 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 47
Study 34961531 — intervention group
Group type: EXPERIMENTAL
Intervention: i-ACT training
Number of subjects: 47
Study 34601551 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose spice diet (MSD) 3.285 g · d‐1 · 2100 kcal‐1 for 4 weeks
Number of subjects: 63
Study 34601551 — intervention group
Group type: COMPARATOR
Intervention: High-dose spice diet (HSD) 6.571 g · d‐1 · 2100 kcal‐1 for 4 weeks
Number of subjects: 63
Study 33111740 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki protocol (n=31)
Number of subjects: 124
Study 33111740 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (n=59)
Number of subjects: 124
Study 34213748 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Interventions (MBIs) training for 6 months
Number of subjects: 160
Study 32060566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311
Study 32060566 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg/day VK2
Number of subjects: 311
Study 32060566 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 µg/day VK2
Number of subjects: 311
Study 32060566 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-supplementation with calcium (500 mg/day) and vitamin D3 (10 µg/day)
Number of subjects: 311
Study 33438181 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 837
Study 33438181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 837
Study 33771659 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss Collagen
Number of subjects: 66
Study 33771659 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated sockets)
Number of subjects: 66
Study 34496821 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior controllable antedisplacement and fusion (ACAF)
Number of subjects: 164
Study 34496821 — intervention group
Group type: COMPARATOR
Intervention: Conventional posterior laminoplasty (LAMP)
Number of subjects: 164
Study 34496821 — intervention group
Group type: EXPERIMENTAL
Intervention: ACAF
Number of subjects: 164
Study 34496821 — intervention group
Group type: COMPARATOR
Intervention: LAMP
Number of subjects: 164
Study 35399221 — intervention group
Group type: EXPERIMENTAL
Intervention: PDCA home nursing (research group)
Number of subjects: 64
Study 35399221 — intervention group
Group type: COMPARATOR
Intervention: Routine home nursing (control group)
Number of subjects: 64
Study 33555266 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support (informational support)
Number of subjects: 253
Study 33555266 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support (emotional support)
Number of subjects: 253
Study 33555266 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived health information sensitivity
Number of subjects: 253
Study 33555266 — intervention group
Group type: EXPERIMENTAL
Intervention: Privacy concerns
Number of subjects: 253
Study 32602966 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 21
Study 32602966 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 21
Study 33503628 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic underpinnings of psychiatric conditions handout
Number of subjects: 417
Study 33503628 — intervention group
Group type: EXPERIMENTAL
Intervention: Agency-oriented handout focusing on gene-environment interactions
Number of subjects: 417
Study 33503628 — intervention group
Group type: COMPARATOR
Intervention: Both handouts
Number of subjects: 417
Study 35294330 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT) for 16 weeks
Number of subjects: 52
Study 35294330 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (CT) for 8 weeks after 8 weeks of AT
Number of subjects: 52
Study 35294330 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) performing low-intensity therapeutic exercises in water
Number of subjects: 52
Study 33040841 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone/gabapentin combination (2.5/25, 10/100, 30/300)
Number of subjects: 29
Study 33040841 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone/gabapentin combination (10/100)
Number of subjects: 29
Study 33040841 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 29
Study 32071186 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) troponin T measurement
Number of subjects: 866
Study 32071186 — intervention group
Group type: COMPARATOR
Intervention: Presentation at the emergency department (ED)
Number of subjects: 866
Study 34914338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 250 mg daily (AA250 arm)
Number of subjects: 45
Study 34914338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 500 mg daily (AA500 arm)
Number of subjects: 45
Study 34914338 — intervention group
Group type: COMPARATOR
Intervention: No intervention (NI arm)
Number of subjects: 45
Study 34181225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish/seafood consumption among food insecure FN participants in eastern regions (Ontario, Quebec/Labrador, Atlantic region)
Number of subjects: 6258
Study 34181225 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional food (TF) consumption including fish/seafood among severely food insecure men
Number of subjects: 6258
Study 34181225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish/seafood as a source of nutrients
Number of subjects: 6258
Study 34181225 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to fish/seafood access
Number of subjects: 6258
Study 33065791 — intervention group
Group type: EXPERIMENTAL
Intervention: Xipayi mouth rinse combined with minocycline
Number of subjects: 96
Study 33065791 — intervention group
Group type: COMPARATOR
Intervention: Xipayi mouth rinse
Number of subjects: 96
Study 34996918 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with epinephrine 1:200,000
Number of subjects: 52
Study 34996918 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 ml DW5
Number of subjects: 52
Study 33105146 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (titrated to maximum tolerable dose up to 1.8 mg)
Number of subjects: 24
Study 33105146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33105146 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 24
Study 35599918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (4000 IU weekly)
Number of subjects: 18
Study 35599918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 33865797 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited PLND (external iliac nodes)
Number of subjects: 1440
Study 33865797 — intervention group
Group type: COMPARATOR
Intervention: Extended PLND (external iliac, obturator fossa and hypogastric nodes)
Number of subjects: 1440
Study 33865797 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited PLND
Number of subjects: 1440
Study 33865797 — intervention group
Group type: COMPARATOR
Intervention: Extended PLND
Number of subjects: 1440
Study 34033265 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 5 mg/kg/day
Number of subjects: 219
Study 34033265 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 10 mg/kg/day
Number of subjects: 219
Study 34033265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 32176565 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acid (ω3FA) supplementation for 60 days
Number of subjects: 53
Study 32176565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 33522909 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of cefazolin
Number of subjects: 0
Study 33522909 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 0
Study 32299458 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial revascularization (CABG)
Number of subjects: 600
Study 32299458 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 600
Study 36274362 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow resection margin
Number of subjects: 0
Study 36274362 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based preoperative markers (tumour size > 5 cm, substantial necrosis, non-smooth margins) combined with narrow resection margin
Number of subjects: 0
Study 36274362 — intervention group
Group type: COMPARATOR
Intervention: Wide resection margin
Number of subjects: 0
Study 33289350 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg FT-4101
Number of subjects: 14
Study 33289350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 35565738 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg gluten
Number of subjects: 15
Study 35565738 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg gluten
Number of subjects: 15
Study 35565738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35565738 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten administration (all doses)
Number of subjects: 15
Study 33864584 — intervention group
Group type: EXPERIMENTAL
Intervention: EAAA program (Sexual Assault Resistance Education)
Number of subjects: 0
Study 34529686 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety reduction/prevention program
Number of subjects: 64
Study 34529686 — intervention group
Group type: COMPARATOR
Intervention: No intervention/treatment as usual
Number of subjects: 64
Study 35238902 — intervention group
Group type: EXPERIMENTAL
Intervention: AGN-190584
Number of subjects: 323
Study 35238902 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 323
Study 32739415 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching residents about ACL tear signs during a 2-4 week rotation
Number of subjects: 60
Study 32739415 — intervention group
Group type: COMPARATOR
Intervention: Experience of radiologists
Number of subjects: 60
Study 34272216 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised health profile
Number of subjects: 303
Study 34272216 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 303
Study 34272216 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured telephone consultation
Number of subjects: 303
Study 34272216 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 303
Study 35392153 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 µg/ml)
Number of subjects: 120
Study 35392153 — intervention group
Group type: COMPARATOR
Intervention: Sufentanyl (0.4 µg/ml)
Number of subjects: 120
Study 34449776 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative high-load long-duration inspiratory muscle training (40% of baseline maximal inspiratory pressure targeting a load of 80% by the end of 8 weeks)
Number of subjects: 100
Study 34449776 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy care (Control group)
Number of subjects: 100
Study 34470816 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Weight Clinic (HWC)
Number of subjects: 407
Study 34470816 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Healthy Weight and Your Child (M-HWYC)
Number of subjects: 407
Study 34470816 — intervention group
Group type: COMPARATOR
Intervention: Comparison sites
Number of subjects: 407
Study 34470816 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of M-HWYC and HWC
Number of subjects: 407
Study 32749474 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 0
Study 32749474 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35188555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy (carbon dioxide laser under local anesthesia)
Number of subjects: 199
Study 35188555 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy (total tonsil removal under general anesthesia)
Number of subjects: 199
Study 35188555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy
Number of subjects: 199
Study 35188555 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 199
Study 34840636 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied to Jian yu (LI15), Bi nao (LI14), Jian zhen (SI9), and Jian liao (TE14) acupoints, 30 minutes/day, five days a week, for two weeks.
Number of subjects: 34
Study 34840636 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA) applied 15 mm away from Lou gu (SP7), Di ji (SP8), Jiao xin (KI8), and Zhu bin (KI9) acupoints, 30 minutes/day, five days a week, for two weeks.
Number of subjects: 34
Study 34840636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EA and SEA groups.
Number of subjects: 34
Study 34978861 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadpill containing quarter doses of 4 blood pressure drugs
Number of subjects: 0
Study 34978861 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose monotherapy
Number of subjects: 0
Study 33558153 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM)
Number of subjects: 797
Study 32353035 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital weight management intervention with one-on-one health coaching via app-based video chat
Number of subjects: 683
Study 35962536 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive function training (25 training sessions)
Number of subjects: 32
Study 35962536 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 33118831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms predicting overall survival (OS) and cancer-specific survival (CSS) based on independent prognostic factors identified through Cox analyses.
Number of subjects: 1066
Study 32331020 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL)
Number of subjects: 200
Study 32331020 — intervention group
Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP)
Number of subjects: 200
Study 35283036 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart water bottle (HidrateSpark®; Hydrate Inc.)
Number of subjects: 85
Study 35283036 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary recommendations (DR arm)
Number of subjects: 85
Study 33622057 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthomonas fragariae strain YL19 inoculation (2×10^8 CFU)
Number of subjects: 121
Study 33622057 — intervention group
Group type: COMPARATOR
Intervention: Control (sterile water)
Number of subjects: 121
Study 34147611 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients living alone
Number of subjects: 202
Study 34147611 — intervention group
Group type: COMPARATOR
Intervention: Patients living with someone else
Number of subjects: 202
Study 33118603 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Sensitization Inventory (CSI)
Number of subjects: 2620